type here...

CATEGORIES

Innovations

LATEST

1...111213Page 12 of 13

TRENDING

EDITORS CHOICE

FDA Approves Drug Combination for Treating Mesothelioma

Medika Life -
First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...

Two Gatherings, One Mission: Elevating Life Science Leadership and Communication

Gil Bashe, Medika Life Editor -
Every industry has its signature gatherings, places where thought leaders assemble to shape the next wave of innovation. For those leading in health, life...

“Investigational” Is Payer Code for “Coverage Denied”

Gil Bashe, Medika Life Editor -
Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

Oxycodone No Better in Treating Post-Orthopedic Surgical Pain

Dr. Hesham A. Hassaballa -
The opioid crisis has taken the lives of thousands of people in our country. In fact, according to the CDC, opioid overdose deaths hit...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories